First personalized mRNA cancer vaccine wins Phase 3 trial

rand_longevity · x · 2026-08-23

The first personalized mRNA cancer vaccine has won a Phase 3 trial, marking a historic first. The poster notes that most takes focus on mRNA technology, but the real feat lies in building from scratch, understanding why this failed for 30 years, and what has changed. A detailed technical thread is linked.

Original post →

More from Apps

Apps channel →